1 | TMCI | Treace Medical Concepts, Inc. | $4 | -64.02% | 11.577 M | Treace Medical Concepts, Inc.15 days ago TREACE MEDICAL NAMED FIRST MEDICAL DEVICE PARTNER AND OFFICIAL FOOT AND ANKLE SOLUTION PARTNER OF THE PPA TOUR News partnership to help pickleball players of all levels with bunions and related midfoot deformities to “get back on their feet” and out on the court partnership to help pickleball players of all levels with bunions and related midfoot deformities to “get back on their feet” and out on the court News 15 days ago | Buy |
2 | DV | DoubleVerify Holdings, Inc. | $18.36 | -39.96% | 17.601 M | DoubleVerify Holdings, Inc.2 days ago DOUBLEVERIFY REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News new york--(business wire)--doubleverify (“dv”) (nyse: dv), one of the leading software platforms for digital media measurement, data and analytics, today announced financial results for the first quarter ended march 31, 2024. “we made solid progress across multiple growth vectors in the first quarter, ending the period above the high end of our guidance,” said mark zagorski, ceo of doubleverify. “we enhanced and scaled our independently accredited core verification and performance solutions acr. News 2 days ago | Buy |
3 | INSP | Inspire Medical Systems, Inc. | $161.54 | -34.23% | 3.93 M | Inspire Medical Systems, Inc.2 days ago INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND UPDATES 2024 OUTLOOK News inspire reports year-over-year revenue growth of 28% in the first quarter and expects profitability for the full year 2024 News 2 days ago | Buy |
4 | TRIP | TripAdvisor, Inc. | $17.91 | -29.73% | 25.009 M | TripAdvisor, Inc.23 hours ago TRIPADVISOR, INC. EARNINGS PRESS RELEASE AVAILABLE ON COMPANY'S INVESTOR RELATIONS SITE News needham, mass. , may 8, 2024 /prnewswire/ -- tripadvisor, inc. (nasdaq: trip) issued its first quarter 2024 earnings press release which is available now at ir.tripadvisor.com. News 23 hours ago | Buy |
5 | DH | Definitive Healthcare Corp. | $5.26 | -27.52% | 4.2 M | Definitive Healthcare Corp.16 days ago DEFINITIVE HEALTHCARE ANNOUNCES TIMING OF ITS FIRST QUARTER 2024 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST News framingham, mass., april 23, 2024 (globe newswire) -- definitive healthcare corp. (“definitive healthcare”) (nasdaq: dh), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended march 31, 2024, on tuesday, may 7, 2024 after market close. the company will host a conference call and webcast at 5:00 pm (et) / 2:00 pm (pt) to discuss the company's financial results. News 16 days ago | Buy |
6 | SIGA | SIGA Technologies Inc. | $7.64 | -27.01% | 3.543 M | SIGA Technologies Inc.8 days ago SIGA TECHNOLOGIES TO HOST BUSINESS UPDATE CALL ON MAY 7 FOLLOWING RELEASE OF FIRST-QUARTER 2024 FINANCIAL RESULTS News new york, may 01, 2024 (globe newswire) -- siga technologies, inc. (siga) (nasdaq: siga), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 p.m. et on tuesday, may 7, 2024. participating in the call will be diem nguyen, chief executive officer, and daniel luckshire, chief financial officer. News 8 days ago | N/A |
7 | SMLR | Semler Scientific, Inc. | $20.96 | -25.54% | 434.702 K | Semler Scientific, Inc.2 days ago SEMLER SCIENTIFIC® REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News 2024 q1 highlights compared to the corresponding period of 2023: first quarter revenues were $15.9 million, a decrease of 13% first quarter net income was $6.1 million, an increase of 22% cash, cash equivalents and restricted cash balance increased to $62.9 million santa clara, calif. , may 7, 2024 /prnewswire/ -- semler scientific, inc. (nasdaq: smlr), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today reported financial results for the first quarter ended march 31, 2024. News 2 days ago | N/A |
8 | ZI | ZoomInfo Technologies Inc. | $12.13 | -24.31% | 23.492 M | ZoomInfo Technologies Inc.24 days ago ZOOMINFO TO REPORT FINANCIAL RESULTS FOR FIRST QUARTER 2024 ON MAY 7, 2024 News vancouver, wash.--(business wire)--zoominfo (nasdaq: zi), the go-to-market platform to find, acquire, and grow customers, today announced that it will publish financial results for the first quarter 2024 following the close of u.s. financial markets on tuesday, may 7, 2024. the news release and any accompanying materials will be posted to the investor relations portion of zoominfo's website at https://ir.zoominfo.com/. on that day, zoominfo management will host a conference call and webcast at. News 24 days ago | Buy |
9 | LZ | LegalZoom.com, Inc. | $9.47 | -22.31% | 3.34 M | LegalZoom.com, Inc.2 days ago LEGALZOOM REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News mountain view, calif., may 07, 2024 (globe newswire) -- legalzoom.com, inc. (nasdaq: lz), the no. 1 choice in online small business formations, today announced results for its first quarter ended march 31, 2024. News 2 days ago | Buy |
10 | MIND | MIND Technology, Inc. | $4.5 | -22.01% | 108.658 K | MIND Technology, Inc.22 hours ago MIND TECHNOLOGY ANNOUNCES NEW DATE FOR VIRTUAL SPECIAL MEETING OF PREFERRED STOCKHOLDERS AND REVISED PROPOSAL News the woodlands, texas , may 8, 2024 /prnewswire/ -- mind technology, inc. ("mind" or the "company") (nasdaq: mind) (nasdaq: mindp) announced today that the previously announced virtual special meeting of holders of its 9% series a cumulative preferred stock (the "preferred stock") to approve an amendment to the certificate of designations, preferences and rights of the preferred stock has been rescheduled for june 13, 2024. additionally, the proposed amendment has been revised such that each share of preferred stock would be converted into 3.9 shares of common stock, $0.01 par value per share (the "common stock"), rather than the 2.7 shares initially proposed, at the sole discretion of the company's board of directors at any time prior to july 31, 2024 (the "revised proposal"). News 22 hours ago | N/A |
11 | YMAB | Y-mAbs Therapeutics, Inc. | $13.64 | -20.74% | 1.365 M | Y-mAbs Therapeutics, Inc.13 days ago Y-MABS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS ON MAY 7, 2024 News the company will host a conference call and webcast on wednesday, may 8, 2024 at 8:00 a.m. et the company will host a conference call and webcast on wednesday, may 8, 2024 at 8:00 a.m. et News 13 days ago | Buy |
12 | NWTN | NWTN Inc. | $3.47 | -20.59% | 94.203 K | NWTN Inc.4 months ago NWTN ANNOUNCES FINANCIAL RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023 News dubai, uae, jan. 4, 2024 /prnewswire/ -- nwtn inc. (nasdaq: nwtn), an eco-conscious mobility technology company bringing passenger-centric green premium mobility solutions to the world ("nwtn" or the "company"), today announced its unaudited financial results for the six months ended june 30, 2023. financial highlights (all results compared to the same period of prior year period unless otherwise noted) revenue was $0.6 million, which was nil for the six months ended june 30, 2022. News 4 months ago | N/A |
13 | ATEC | Alphatec Holdings, Inc. | $10.83 | -20.29% | 7.353 M | Alphatec Holdings, Inc.7 days ago ATEC TO PRESENT AT UPCOMING CONFERENCES News carlsbad, calif.--(business wire)--alphatec holdings, inc. (nasdaq: atec), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: the bank of america healthcare conference at the encore hotel in las vegas, nv, on may 15, 2024, at 1:40pm pt the barclays medtech west coast bus tour at the fairmont grand in del mar, ca, on may 20, 2024, at 8:00am pt the wells fargo west c. News 7 days ago | Buy |
14 | GO | Grocery Outlet Holding Corp. | $20.9 | -19.32% | 8.794 M | Grocery Outlet Holding Corp.2 days ago GROCERY OUTLET HOLDING CORP. ANNOUNCES FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS News q1 fiscal 2024 net sales increased 7.4% q1 fiscal 2024 comparable store sales grew 3.9% , driven by a 7.0% increase in transactions company updates key guidance for fiscal 2024 News 2 days ago | Buy |
15 | SHOP | Shopify Inc. | $62.38 | -19.05% | 51.831 M | Shopify Inc.23 hours ago SHOPIFY ANNOUNCES FIRST-QUARTER 2024 FINANCIAL RESULTS News revenue up 23%, and up 29% adjusting for the sale of our logistics businesses; gross profit up 33%; free cash flow margin doubled year over year to 12% internet, everywhere--(newsfile corp. - may 8, 2024) - shopify inc. (nyse, tsx: shop), a provider of essential internet infrastructure for commerce, announced today financial results for the quarter ended march 31, 2024. "you're seeing the strongest version of shopify in our history. News 23 hours ago | Buy |
16 | CYRX | CryoPort, Inc. | $13.35 | -18.6% | 922.995 K | CryoPort, Inc.21 hours ago INVESTIGATION ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST CRYOPORT, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM News los angeles, ca / accesswire / may 8, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of cryoport, inc. ("cryoport" or "the company") (nasdaq:cyrx) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. News 21 hours ago | Buy |
17 | RPD | Rapid7, Inc. | $37.37 | -18.41% | 7.943 M | Rapid7, Inc.2 days ago RAPID7 ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS News boston, may 07, 2024 (globe newswire) -- rapid7, inc. (nasdaq: rpd), a leader in extended risk and threat detection, today announced its financial results for the first quarter of 2024. News 2 days ago | Buy |
18 | CZOO | Cazoo Group Ltd | $7.7 | -17.96% | 1.213 M | Cazoo Group Ltd2 months ago CAZOO ANNOUNCES TRANSITION TO PURE-PLAY AUTOMOTIVE MARKETPLACE BUSINESS MODEL News london & new york--(business wire)--cazoo group ltd (nyse: czoo) (“cazoo” or “the company”), the uk online used car platform which makes buying and selling a car as simple as ordering any other product online, announces its intention to transition to a marketplace business model, leveraging the strength of the cazoo brand and the market-leading ecommerce platform it has built in online automotive retailing for the benefit of the 13,000 car dealers operating in the uk's highly fragmented used ca. News 2 months ago | Buy |
19 | NATR | Nature's Sunshine Products, Inc. | $15.76 | -17.57% | 130.434 K | Nature's Sunshine Products, Inc.2 days ago NATURE'S SUNSHINE REPORTS STRONG FIRST QUARTER 2024 RESULTS News lehi, utah, may 07, 2024 (globe newswire) -- nature's sunshine products, inc. (nasdaq: natr) (nature's sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the first quarter ended march 31, 2024. News 2 days ago | N/A |
20 | ALIT | Alight, Inc. | $7.71 | -17.01% | 21.992 M | Alight, Inc.23 hours ago ALIGHT REPORTS FIRST QUARTER 2024 RESULTS News lincolnshire, ill.--(business wire)--alight, inc. (nyse: alit), a leading cloud-based provider of integrated digital human capital and business solutions, today reported results for the first quarter ended march 31, 2024. “it has been an exciting start to the year for alight, with the announced agreement to sell our payroll and professional services business and create a world-class partnership with h.i.g. to further accelerate our transformation,” said chief executive officer stephan scholl. “. News 23 hours ago | Buy |
21 | NRC | National Research Corporation | $29.7 | -16.64% | 88.045 K | National Research Corporation2 days ago NATIONAL RESEARCH CORPORATION ANNOUNCES FIRST QUARTER RESULTS News lincoln, neb.--(business wire)--national research corporation, dba nrc health, (nasdaq:nrc) today announced results for the first quarter 2024. ceo commentary michael hays, chief executive officer, commented: “nrc continues to be strongly positioned for growth in our expanding markets. our decades of benchmarks and trusted thought leadership afford healthcare insights unavailable to most competitors, while our client service remains unmatched, and we continue to roll out innovative new products. News 2 days ago | N/A |
22 | IAS | Integral Ad Science Holding Corp. | $8.26 | -16.57% | 4.641 M | Integral Ad Science Holding Corp.2 days ago INVESTORS WHO LOST MONEY ON INTEGRAL AD SCIENCE HOLDING CORP. SHOULD CONTACT LEVI & KORSINSKY ABOUT AN ONGOING INVESTIGATION - IAS News new york, ny / accesswire / may 7, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of integral ad science holding corp. ("integral ad science") (nasdaq:ias) concerning possible violations of federal securities laws. on february 27, 2024, integral guided its top-line growth would be cut in half for the first quarter 2024. News 2 days ago | Buy |
23 | FLYW | Flywire Corporation - Voting | $17.16 | -16.46% | 10.461 M | Flywire Corporation - Voting2 days ago FLYWIRE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News first quarter revenue increased 21% year-over-year first quarter revenue less ancillary services increased 24% year-over-year company provides second quarter and fiscal-year 2024 outlook boston, may 07, 2024 (globe newswire) -- flywire corporation (nasdaq: flyw) (“flywire” or the “company”) a global payments enablement and software company, today reported financial results for its first quarter ended march 31, 2024. "we are pleased with our 2024 first quarter results, where we signed more than 200 new clients, the highest the company has signed in a quarter," said mike massaro, ceo of flywire. News 2 days ago | Buy |
24 | EYE | National Vision Holdings, Inc. | $14.96 | -16.31% | 3.785 M | National Vision Holdings, Inc.1 day ago NATIONAL VISION HOLDINGS, INC. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News duluth, ga.--(business wire)--national vision holdings, inc. (nasdaq: eye) (“national vision” or the “company”) today reported its financial results for the first quarter ended march 30, 2024. “we delivered first quarter results in line with our expectations, reflecting a sequential improvement in the second half of the period. while weather and a slower start to the tax refund season at the beginning of the quarter adversely impacted sales, our teams remained focused on the areas of our busine. News 1 day ago | Buy |
25 | CXDO | Crexendo, Inc. | $3.9 | -16.09% | 258.703 K | Crexendo, Inc.2 days ago CREXENDO ANNOUNCES FIRST QUARTER 2024 RESULTS News phoenix, az / accesswire / may 7, 2024 / crexendo, inc. (nasdaq:cxdo), an award-winning premier provider of cloud communication platform and services, video collaboration and managed it services designed to provide enterprise-class cloud solutions to any size business, today announced financial results for the first quarter ended march 31, 2024. first quarter financial highlights: total revenue increased 14% year-over-year to $14.3 million gaap net income of $434,000, or $0.02 per basic common share and $0.01 per diluted common share non-gaap net income of $1.9 million, or $0.07 per basic common share and $0.06 per diluted common share financial results for the first quarter of 2024 total revenue: consolidated total revenue for the first quarter of 2024 increased 14%, or $1.8 million, to $14.3 million compared to $12.5 million for the first quarter of 2023. News 2 days ago | Hold |
26 | SHLS | Shoals Technologies Group, Inc. | $7.39 | -16.08% | 11.362 M | Shoals Technologies Group, Inc.15 hours ago DEADLINE ACTION NOTICE: THE SCHALL LAW FIRM ENCOURAGES INVESTORS IN SHOALS TECHNOLOGIES GROUP, INC. WITH LOSSES OF $100,000 TO CONTACT THE FIRM News los angeles, ca / accesswire / may 8, 2024 / the schall law firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against shoals technologies group, inc. ("shoals" or "the company") (nasdaq:shls) for violations of 10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between may 17, 2022 and november 7, 2023, inclusive (the "class period"), are encouraged to contact the firm before may 21, 2024. News 15 hours ago | Buy |
27 | ODP | The ODP Corporation | $43.81 | -15.59% | 851.885 K | The ODP Corporation1 day ago THE ODP CORPORATION ANNOUNCES FIRST QUARTER 2024 RESULTS News boca raton, fla.--(business wire)--the odp corporation announces first quarter 2024 results. News 1 day ago | Hold |
28 | BCG | Binah Capital Group, Inc. | $5.07 | -15.54% | 3.667 K | Binah Capital Group, Inc.10 days ago BINAH CAPITAL GROUP CELEBRATES SUCCESSFUL COMPLETION OF PUBLIC LISTING WITH OPENING BELL RINGING CEREMONY AT NASDAQ News leading financial services enterprise to ring the nasdaq opening bell on tuesday, april 30, 2024 new york , april 29, 2024 /prnewswire/ -- binah capital group, inc. ("binah capital") (nasdaq: bcg), a leading consolidator of financial services companies focused on wealth management, announced today that it will ring the nasdaq marketsite opening bell on tuesday, april 30, 2024. the ceremony highlights the firm's recent milestone of a successful public listing on the nasdaq. News 10 days ago | N/A |
29 | BENF | Beneficient | $4.69 | -15.5% | 598.998 K | Beneficient6 days ago BENEFICIENT REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE RULE News dallas, may 03, 2024 (globe newswire) -- beneficient (the “company”) (nasdaq: benf), a technology-enabled platform providing liquidity and related trust and custody services to holders of alternative assets through its proprietary online platform, altaccess, today announced that it has received notice from the nasdaq stock market llc (“nasdaq”) that it has regained compliance with the minimum bid price requirement under nasdaq listing rule 5550(a)(2). the notice confirmed that the company's securities will continue to be listed and traded on nasdaq. News 6 days ago | N/A |
30 | CIX | CompX International Inc. | $29.05 | -15.01% | 21.868 K | CompX International Inc.2 days ago COMPX REPORTS FIRST QUARTER 2024 RESULTS News dallas, texas, may 07, 2024 (globe newswire) -- compx international inc. (nyse american: cix) announced today sales of $38.0 million for the first quarter of 2024 compared to $41.2 million in the same period of 2023. operating income was $3.7 million in the first quarter of 2024 compared to $7.0 million in the same period of 2023. net income was $3.7 million, or $.31 per basic and diluted common share, for the first quarter of 2024 compared to $6.1 million, or $.49 per basic and diluted common share, in the same period of 2023. News 2 days ago | N/A |
31 | INBS | Intelligent Bio Solutions Inc. | $2.46 | -14.88% | 161.154 K | Intelligent Bio Solutions Inc.22 hours ago INTELLIGENT BIO SOLUTIONS INC. REPORTS FISCAL 2024 THIRD QUARTER AND NINE-MONTH FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS News year-over-year revenue increased 80% for the fiscal third quarter and 193% for the nine months ended march 31, 2024 News 22 hours ago | N/A |
32 | ZVSA | ZyVersa Therapeutics, Inc. | $5.57 | -13.91% | 123.514 K | ZyVersa Therapeutics, Inc.10 days ago ZYVERSA THERAPEUTICS ANNOUNCES PUBLICATION REINFORCING THE RATIONALE FOR INHIBITING ASC WITH IC 100 TO POTENTIALLY ATTENUATE CARDIAC COMORBIDITIES IN PATIENTS WITH ALZHEIMER'S DISEASE News nlrp1 & pyrin govern inflammation in alzheimer's disease, and release of inflammasome laden extracellular vesicles induces cardiovascular inflammation. News 10 days ago | N/A |
33 | VTEX | VTEX | $7.01 | -13.84% | 2.007 M | VTEX15 days ago VTEX TO HOLD ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS ON MAY 24, 2024 News new york--(business wire)--vtex (nyse: vtex), the composable and complete commerce platform for premier brands and retailers, announces that its annual general meeting of shareholders ("general meeting") is going to be held on may 24, 2024 at 10:00 a.m. (eastern time) at floor 4, willow house cricket square, grand cayman, ky1-9010, cayman islands. the convening notice, including the agenda for the general meeting, the form of proxy card and the relevant materials for the general meeting are ava. News 15 days ago | Buy |
34 | NUVO | Holdco Nuvo Group D.G Ltd. | $2.47 | -13.33% | 913.199 K | N/A | N/A |
35 | UPLD | Upland Software, Inc. | $2.92 | -13.09% | 473.321 K | Upland Software, Inc.7 days ago UPLAND SOFTWARE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News austin, texas--(business wire)--upland software, inc. (nasdaq: upld), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the first quarter 2024 and issued guidance for its second quarter and full year of 2024. first quarter 2024 financial highlights total revenue was $70.7 million, a decrease of 8% from $77.1 million in the first quarter of 2023. subscription and support revenue was $67.1 million, a decrease of 8% from $72.9 million in. News 7 days ago | Hold |
36 | ESPR | Esperion Therapeutics, Inc. | $2.07 | -12.87% | 11.555 M | Esperion Therapeutics, Inc.2 days ago ESPERION REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News – q1 total revenue grew 467% y/y to $137.7 million, reflecting strong growth globally – – q1 u.s. net product revenue grew 46% y/y to $24.8 million – – q1 retail prescription equivalents grew 43% y/y and 6% q/q, increased momentum from label expansions expected throughout 2024 – – received u.s. fda approval of broad new label expansions for nexletol ® (bempedoic acid) tablet and nexlizet ® (bempedoic acid and ezetimibe) tablet, becoming the first ldl-c lowering non-statins to prevent heart attacks and reduce cardiovascular risk in primary and secondary prevention patients – – received positive opinion from the committee for medical products for human use (chmp); european commission decision for expanded labels anticipated in q2 2024 – – conference call and webcast today at 8:00 a.m. et – ann arbor, mich. News 2 days ago | Buy |
37 | PALI | Palisade Bio, Inc. | $6.89 | -12.81% | 57.095 K | Palisade Bio, Inc.2 days ago PALISADE BIO APPOINTS MARGERY FISCHBEIN TO ITS BOARD OF DIRECTORS News wall street and biotech industry veteran with expertise across corporate finance, business development, m&a, licensing, and strategic alliance transactions, globally News 2 days ago | Buy |
38 | MEG | Montrose Environmental Group, Inc. | $41.73 | -12.28% | 506.722 K | Montrose Environmental Group, Inc.2 days ago MONTROSE ENVIRONMENTAL GROUP ANNOUNCES FIRST QUARTER 2024 RESULTS News little rock, ark.--(business wire)--montrose environmental group, inc. (the “company,” “montrose” or “meg”) (nyse: meg) today announced results for the first quarter ended march 31, 2024. montrose chief executive officer and director, vijay manthripragada, commented, “the momentum in our business continues as we start 2024 with solid first quarter results. our organic growth and outlook remain very strong, and our cadence of strategic acquisitions has increased. we saw strength across our busin. News 2 days ago | Buy |
39 | STAA | STAAR Surgical Company | $40.97 | -12.19% | 1.093 M | STAAR Surgical Company8 days ago STAAR SURGICAL STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENTS OF NANCY SABIN AS CHIEF MARKETING OFFICER AND NATHANIEL SISITSKY AS GENERAL COUNSEL News lake forest, calif.--(business wire)--staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of the evo family of implantable collamer® lenses (evo icl™) for myopia, astigmatism and presbyopia, today announced nancy sabin has been named chief marketing officer and nathaniel sisitsky has been named general counsel. both will serve on the company's executive committee and report to tom frinzi, staar surgical's president and ceo. “we are thrilled to strengthen the sta. News 8 days ago | Buy |
40 | MASI | Masimo Corporation | $119.51 | -12.13% | 1.85 M | Masimo Corporation21 hours ago MASIMO TO PRESENT IN BOFA SECURITIES HEALTH CARE CONFERENCE News irvine, calif.--(business wire)--masimo (nasdaq: masi) today announced that its management will participate in the bofa securities health care conference on wednesday, may 15, 2024 at 4:20 p.m. pacific time. a live webcast of the presentation will be available on the masimo website at www.masimo.com. a replay of the webcast will be available following the live presentation. about masimo masimo (nasdaq: masi) is a global technology company that develops and produces a wide array of industry-lead. News 21 hours ago | Buy |
41 | NVRO | Nevro Corp. | $10.18 | -11.71% | 574.465 K | Nevro Corp.2 days ago NEVRO REPORTS FIRST-QUARTER 2024 FINANCIAL RESULTS News announces additional restructuring steps to advance strategy and accelerate profitability raises adjusted ebitda guidance and reaffirms revenue guidance for full-year 2024 promotes christofer christoforou to chief operating officer redwood city, calif. , may 7, 2024 /prnewswire/ -- nevro corp. (nyse: nvro), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results. News 2 days ago | Buy |
42 | RENT | Rent the Runway, Inc. | $13.45 | -11.69% | 187.569 K | Rent the Runway, Inc.29 days ago RENT THE RUNWAY, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS News exceeded revenue and adjusted ebitda guidance for q4 2023 expect revenue growth in fy 2024 through focus on marketing, product innovation and strong customer retention. committed to achieving free cash flow breakeven for fy 2024. News 29 days ago | Buy |
43 | JANX | Janux Therapeutics, Inc. | $54.35 | -11.63% | 1.353 M | Janux Therapeutics, Inc.2 months ago JANUX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS News san diego--(business wire)---- $janx--janux therapeutics reports fourth quarter and full year 2023 financial results and business highlights. News 2 months ago | Buy |
44 | LFLY | Leafly Holdings, Inc. | $2.59 | -11.6% | 32.794 K | Leafly Holdings, Inc.2 days ago LEAFLY NAMES PETER LEE PRESIDENT AND CHIEF OPERATING OFFICER News seattle--(business wire)--leafly holdings, inc. (“leafly” or “the company”) (nasdaq: lfly), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced that peter lee will join leafly as president and chief operating officer, leading new monetization efforts, operations, and corporate development, and deepening partnerships with leafly's customers. he will remain a member of leafly's board of directors. “we are excited to welcome peter to our team. his c. News 2 days ago | N/A |
45 | WISA | WiSA Technologies, Inc. | $3.45 | -11.54% | 534.86 K | WiSA Technologies, Inc.7 days ago WISA TECHNOLOGIES REGAINS NASDAQ COMPLIANCE WITH MINIMUM BID PRICE RULE News beaverton, ore.--(business wire)--wisa technologies, inc. (nasdaq: wisa, the “company”), a leading innovator in wireless audio technology for intelligent devices and next-generation home entertainment systems, has received confirmation from the nasdaq stock market llc (“nasdaq”) that it has regained compliance with the minimum bid price requirement of $1.00 per share under nasdaq listing rule 5550(a)(2). the company continues to be subject to a mandatory panel monitor until april 29, 2025. if,. News 7 days ago | Buy |
46 | APM | Aptorum Group Limited | $4.57 | -11.43% | 38.701 K | Aptorum Group Limited9 days ago APTORUM GROUP LIMITED REPORTS 2023 FISCAL YEAR END FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE News new york & london--(business wire)--aptorum group limited (nasdaq: apm) (“aptorum group” or “we”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial results for the fiscal year ended december 31, 2023, and provided an update on corporate developments. mr. ian huen, chief executive officer and executive director of aptorum group, commented, “throughout 2023, we have maintained a. News 9 days ago | N/A |
47 | ETAO | Etao International Co., Ltd. | $2.48 | -11.43% | 105.789 K | Etao International Co., Ltd.2 months ago ETAO INTERNATIONAL CO., LTD. ANNOUNCES 1 FOR 20 REVERSE SHARE SPLIT, INCREASE OF AUTHORIZED SHARES AND ALTERATION TO ITS SHARE CAPITAL News this press release has been corrected to include further details regarding the reverse stock split of etao international co., ltd. we hereby issue a formal amendment to supersede our previously released press release dated march 19, 2024. News 2 months ago | N/A |
48 | PYPD | PolyPid Ltd. | $4.31 | -11.32% | 7.791 K | PolyPid Ltd.23 hours ago POLYPID PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News more than 200 patients enrolled in ongoing shield ii phase 3 trial of d-plex 100 for the prevention of abdominal colorectal surgical site infections News 23 hours ago | Buy |
49 | MNDR | Mobile-health Network Solutions | $2.46 | -11.19% | 1.748 M | Mobile-health Network Solutions9 days ago MOBILE-HEALTH NETWORK SOLUTIONS OPENS NEW RETAIL PHARMACY News singapore, april 30, 2024 (globe newswire) -- mobile-health network solutions (nasdaq: mndr) (“manadr” or “the company”), a leading asia-pacific telehealth provider, today announced the grand opening of manapharma pharmacy, the company's new retail pharmacy, at 12 noon local time. News 9 days ago | N/A |
50 | EDIT | Editas Medicine, Inc. | $5.05 | -11.18% | 3.447 M | Editas Medicine, Inc.23 hours ago EDITAS MEDICINE ANNOUNCES FIRST QUARTER 2024 RESULTS AND BUSINESS UPDATES News completed adult cohort enrollment and enrolled multiple patients in the adolescent cohort of the phase 1/2/3 ruby clinical trial of reni-cel for severe sickle cell disease News 23 hours ago | Buy |
51 | AVDL | Avadel Pharmaceuticals plc | $16.2 | -10.89% | 3.404 M | Avadel Pharmaceuticals plc23 hours ago AVADEL PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News -- generated $27.2 million in net revenue from sales of lumryz™ -- -- through march 31, greater than 2,800 patients enrolled in avadel's ryzup patient support services and more than 1,700 patients initiated therapy -- News 23 hours ago | Buy |
52 | AVTX | Avalo Therapeutics, Inc. | $11.82 | -10.79% | 141.744 K | Avalo Therapeutics, Inc.1 month ago AVALO THERAPEUTICS APPOINTS BIOTECH LEADERS TO BOARD OF DIRECTORS News wayne, pa. and rockville, md., april 02, 2024 (globe newswire) -- avalo therapeutics, inc. (nasdaq: avtx) today announced the addition of multiple biotech leaders to its board of directors. the avalo board brings together a team with expertise spanning finance, business operations, drug discovery and clinical development. News 1 month ago | Hold |
53 | EFSH | 1847 Holdings LLC | $2.4 | -10.78% | 176.587 K | 1847 Holdings LLC3 days ago 1847 RE-ENGAGES SHAREINTEL TO INVESTIGATE POTENTIALLY IMPROPER AND ILLEGAL TRADING ACTIVITY IN THE COMPANY'S COMMON STOCK News new york, ny / accesswire / may 6, 2024 / 1847 holdings llc("1847" or the "company") (nyse american:efsh), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, today reports it has re-engaged shareholder intelligence services, llc ("shareintel") to utilize their patented, proprietary service offerings to obtain share trading analytic metrics designed to help coordinate, monitor and enhance corporate governance, shareholder communication, regulatory compliance and surveillance of trading in the company's shares in an effort to allow company to better monitor trading activity, including potential violations of sec regulation sho, which governs stock and option share locate, closeout and fail to deliver requirements. mr. ellery w. News 3 days ago | N/A |
54 | CLVT | Clarivate Plc | $6.21 | -10.72% | 5.278 M | Clarivate Plc1 day ago CLARIVATE REPORTS FIRST QUARTER 2024 RESULTS News — reaffirms 2024 outlook — london , may 8, 2024 /prnewswire/ -- clarivate plc (nyse: clvt) (the "company" or "clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended march 31, 2024. first quarter 2024 financial highlights revenues of $621.2 million decreased 1.3% organic revenues decreased 1.7%, as an increase in subscription revenues of 2.4% was more than offset by a decrease in transactional and other revenues of 11.4% and re-occurring revenues of 5.1% net loss attributable to ordinary shares of $93.8 million; net loss per diluted share of $0.14 adjusted net income(1) of $103.5 million decreased 20.9%; adjusted diluted eps(1) of $0.14 decreased 22.2% or $0.04 adjusted ebitda(1) of $236.3 million decreased 6.5%; adjusted ebitda margin(1) of 38.0% decreased 220 basis points primarily due to lower revenues net cash provided by operating activities of $176.2 million decreased $51.3 million; free cash flow(1) of $111.8 million decreased $56.4 million primarily due to the timing of working capital "we are making great progress this year on key objectives including product investments and operational initiatives to drive future organic revenue growth," said jonathan gear, chief executive officer. News 1 day ago | Buy |
55 | AGBA | AGBA Group Holding Limited | $3.4 | -10.53% | 2.551 M | AGBA Group Holding Limited3 days ago EMPOWERING SHAREHOLDERS: AGBA'S US$4B MERGER WITH TRILLER USHERS IN NEW ERA OF VALUE CREATION News los angeles, may 06, 2024 (globe newswire) -- nasdaq-listed, agba group holding limited (“agba” or the “company” or the “group”), the leading one-stop financial supermarket in hong kong reaffirms its unwavering dedication to creating shareholder value through a collaborative team effort and strategic initiatives. since going public via a spac in november 2023, agba's team of over 1,500+ employees has worked tirelessly everyday in delivering steady growth persistently quarter after quarter maintaining our market leadership. News 3 days ago | N/A |
56 | SATS | EchoStar Corporation | $15.54 | -10.46% | 3.027 M | EchoStar Corporation23 hours ago ECHOSTAR ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2024 News englewood, colo. , may 8, 2024 /prnewswire/ -- echostar corporation (nasdaq: sats) announced its financial results for the three months ended march 31, 2024. News 23 hours ago | Strong Buy |
57 | CSTE | Caesarstone Ltd. | $5.92 | -10.44% | 385.288 K | Caesarstone Ltd.23 hours ago CAESARSTONE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News mp menashe, israel--(business wire)--caesarstone ltd. (nasdaq: cste), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its first quarter ended march 31, 2024. yos shiran, caesarstone's chief executive officer commented, “our team has demonstrated resilience and adaptability to start off 2024 while facing persistent global economic headwinds, regulatory changes in australia and the ongoing conflict in israel. despite our quarterly rev. News 23 hours ago | Buy |
58 | BHF | Brighthouse Financial, Inc. | $45.8 | -10.32% | 992.965 K | Brighthouse Financial, Inc.2 days ago BRIGHTHOUSE FINANCIAL ANNOUNCES FIRST QUARTER 2024 RESULTS News charlotte, n.c.--(business wire)--brighthouse financial, inc. ("brighthouse financial" or the "company") (nasdaq: bhf) announced today its financial results for the first quarter ended march 31, 2024. first quarter 2024 results the company reported a net loss available to shareholders of $519 million in the first quarter of 2024, or $8.22 per diluted share, compared with a net loss available to shareholders of $525 million in the first quarter of 2023. during the quarter, as a result of market. News 2 days ago | Hold |
59 | AFRM | Affirm Holdings, Inc. | $31.37 | -10.13% | 17.981 M | Affirm Holdings, Inc.23 hours ago AFFIRM REPORTS THIRD FISCAL QUARTER 2024 RESULTS News san francisco--(business wire)--affirm holdings, inc. (nasdaq: afrm), the payment network that empowers consumers and helps merchants drive growth, today reported financial results for its fiscal 2024 third quarter ended march 31, 2024. the results, which include a shareholder letter furnished to the u.s. securities and exchange commission on form 8-k, can be found in the “events and presentations” section of the company's investor relations website at https://investors.affirm.com/. affirm will. News 23 hours ago | Buy |
60 | NVCT | Nuvectis Pharma, Inc. | $6.47 | -10.01% | 153.806 K | Nuvectis Pharma, Inc.2 days ago NUVECTIS PHARMA, INC. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS News fort lee, n.j., may 07, 2024 (globe newswire) -- nuvectis pharma, inc. (nasdaq: nvct) ("nuvectis" or the "company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the first quarter 2024 and provided an update on recent business progress. News 2 days ago | N/A |
61 | ANDE | The Andersons, Inc. | $50.65 | -9.79% | 252.762 K | The Andersons, Inc.2 days ago THE ANDERSONS, INC. REPORTS FIRST QUARTER RESULTS News maumee, ohio , may 7, 2024 /prnewswire/ -- the andersons, inc. (nasdaq: ande) announces financial results for the first quarter ended march 31, 2024. first quarter highlights: company reported net income attributable to the andersons of $6 million, or $0.16 per diluted share; comparable on an adjusted basis ebitda was $51 million for the quarter renewables reported pretax income of $23 million and adjusted pretax income attributable to the andersons of $13 million on strong operating performance trade generated adjusted pretax income of $9 million nutrient & industrial shows good improvement over q1 2023 "overall, our first quarter results were fairly comparable to last year's first quarter. News 2 days ago | N/A |
62 | CDRE | Cadre Holdings, Inc. | $31 | -9.77% | 798.384 K | Cadre Holdings, Inc.2 days ago CADRE HOLDINGS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News jacksonville, fla.--(business wire)--cadre holdings, inc. (nyse: cdre) (“cadre” or “the company”), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended march 31, 2024. net sales of $137.9 million for the first quarter gross profit margin of 41.8% for the first quarter net income of $6.9 million, or $. News 2 days ago | Buy |
63 | KLG | WK Kellogg Co | $21.91 | -9.72% | 1.25 M | WK Kellogg Co2 days ago WK KELLOGG CO ANNOUNCES FIRST QUARTER FINANCIAL RESULTS; COMPANY REAFFIRMS 2024 GUIDANCE News battle creek, mich. , may 7, 2024 /prnewswire/ -- wk kellogg co (nyse: klg), today published its 2024 first quarter results in documents posted to the company website at https://investor.wkkellogg.com/news-events/events-and-presentations/default.aspx. News 2 days ago | Sell |
64 | FNA | Paragon 28, Inc. | $9.53 | -9.5% | 688.853 K | Paragon 28, Inc.7 days ago PARAGON 28 TO PRESENT AT THE BANK OF AMERICA SECURITIES 2024 HEALTHCARE CONFERENCE News englewood, colo.--(business wire)--paragon 28, inc. (nyse: fna), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that albert dacosta, chairman and ceo, and krissy wright, interim cfo, will participate in a fireside chat at the bank of america securities 2024 healthcare conference on tuesday, may 14, 2024, at 5:00 p.m. pacific time / 6:00 p.m. mountain time. a live webcast, as well as the archived recording, will be available on the i. News 7 days ago | Buy |
65 | QLYS | Qualys, Inc. | $150.26 | -9.47% | 1.518 M | Qualys, Inc.2 days ago QUALYS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS News revenue growth of 12% year-over-year gaap eps: $1.05; non-gaap eps: $1.45 raises 2024 gaap eps guidance to $3.26-$3.50 raises 2024 non-gaap eps guidance to $5.06-$5.30 foster city, calif. , may 7, 2024 /prnewswire/ -- qualys, inc. (nasdaq: qlys), a pioneer and leading provider of disruptive cloud-based it, security and compliance solutions, today announced financial results for the first quarter ended march 31, 2024. News 2 days ago | Buy |
66 | MOND | Mondee Holdings, Inc. | $2.31 | -9.41% | 18.413 K | Mondee Holdings, Inc.9 days ago MONDEE TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 10, 2024 News austin, texas, april 30, 2024 (globe newswire) -- mondee holdings, inc. (nasdaq: mond) (“mondee” or the “company”), a leading artificial intelligence (ai) travel technology company and marketplace with a portfolio of global platforms in the leisure and corporate travel sectors, announced that it will report first quarter 2024 financial results for the period ended march 31, 2024, on friday, may 10, 2024 via an earnings release and accompanying webcast. News 9 days ago | Buy |
67 | TRVI | Trevi Therapeutics, Inc. | $2.63 | -9.24% | 104.683 K | Trevi Therapeutics, Inc.2 days ago TREVI THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES News reaffirms guidance for the phase 2a river trial in refractory chronic cough and human abuse potential (hap) study with topline data for each expected in the second half of 2024 topline results continue to be expected in the first half of 2025 for the phase 2b coral trial in chronic cough in ipf ind cleared with the fda for planned phase 1b trial to evaluate respiratory physiology in ipf patients with varying disease severity management to host a conference call and webcast today at 4:30 p.m. et new haven, conn. News 2 days ago | Buy |
68 | KRNT | Kornit Digital Ltd. | $15.16 | -9.06% | 597.51 K | Kornit Digital Ltd.23 hours ago KORNIT DIGITAL REPORTS FIRST QUARTER 2024 RESULTS News rosh-ha`ayin, israel, may 08, 2024 (globe newswire) -- kornit digital ltd. (“kornit” or the “company”) (nasdaq: krnt), a worldwide market leader in sustainable, on-demand, digital fashionx and textile production technologies, reported today its results for the first quarter ended march 31, 2024. News 23 hours ago | Buy |
69 | KYTX | Kyverna Therapeutics, Inc. | $12.43 | -8.94% | 292.272 K | Kyverna Therapeutics, Inc.28 days ago KYVERNA THERAPEUTICS TO ATTEND THE 2024 AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING IN DENVER, CO, WITH DATA ON KYV-101 IN THE TREATMENT OF PATIENTS WITH NEUROLOGICAL AUTOIMMUNE DISEASES News poster #14-006 describes the first successful treatment of concomitant myasthenia gravis and lambert-eaton myasthenic syndrome with autologous cd19-targeted car-t cells kyverna to host a conference call on april 16 to review recent named-patient experience in patients suffering from multiple sclerosis and myasthenia gravis emeryville, calif. , april 11, 2024 /prnewswire/ -- kyverna therapeutics, inc. (nasdaq: kytx), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today its attendance at the 2024 annual meeting of the american academy of neurology to be held in denver, colorado, starting on april 13. News 28 days ago | N/A |
70 | BTAI | BioXcel Therapeutics, Inc. | $2.14 | -8.94% | 701.089 K | BioXcel Therapeutics, Inc.14 days ago BIOXCEL THERAPEUTICS TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9, 2024 News new haven, conn., april 25, 2024 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its first quarter 2024 financial results on thursday, may 9, 2024, before the open of the u.s. financial markets. bioxcel therapeutics' management team will also host a conference call and webcast at 8:00 am et that day to discuss the company's financial results and provide a general business update. News 14 days ago | Buy |
71 | ALAB | Astera Labs, Inc. | $69.42 | -8.89% | 4.752 M | Astera Labs, Inc.2 days ago ASTERA LABS ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2024 News santa clara, calif.--(business wire)--astera labs (nasdaq: alab), a global leader in semiconductor-based connectivity solutions for cloud and ai infrastructure, today announced preliminary financial results for the first quarter of fiscal 2024, ended march 31, 2024. “astera labs started the year strong, achieving record revenue in the first quarter, driven by the accelerating deployment of ai infrastructure,” said jitendra mohan, astera labs' chief executive officer. “as hyperscalers embark on. News 2 days ago | N/A |
72 | VOXX | VOXX International Corporation | $5.15 | -8.85% | 58.487 K | VOXX International Corporation2 days ago VOXX INTERNATIONAL CORPORATION SETS DATE TO REPORT ITS FISCAL 2024 FOURTH QUARTER AND YEAR-END RESULTS AND HOST CONFERENCE CALL News orlando, fla. , may 7, 2024 /prnewswire/ -- voxx international corporation (nasdaq: voxx), a leading manufacturer and distributor of automotive and consumer technologies for the global markets, today announced that it will be reporting its fiscal 2024 fourth quarter and year-end results for the period ended february 28, 2024, on tuesday, may 14, 2024, after the market closes. News 2 days ago | N/A |
73 | SDA | SunCar Technology Group Inc. | $7.54 | -8.83% | 249.12 K | SunCar Technology Group Inc.15 days ago SUNCAR TECHNOLOGY GROUP INC. SCHEDULES FISCAL YEAR 2023 EARNINGS CONFERENCE CALL ON TUESDAY, APRIL 30TH AT 5 P.M. ET News new york , april 24, 2024 /prnewswire/ -- suncar technology group inc. (the "company" or "suncar") (nasdaq: sda), an innovative leader in cloud-based b2b auto services and auto e-insurance in china, will announce its financial results for fiscal year 2023 on monday, april 29th before the market opens. suncar will host a conference call on tuesday, april 30, at 5:00 pm et (2:00 pm pt) with the investment community to discuss the company's financial results and provide a business update. News 15 days ago | N/A |
74 | ARDX | Ardelyx, Inc. | $8.49 | -8.81% | 4.064 M | Ardelyx, Inc.2 days ago ARDELYX TO PRESENT ADDITIONAL DATA SUPPORTING FIRST-IN-CLASS IBSRELA® (TENAPANOR) FOR ADULTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION AT THE 2024 DIGESTIVE DISEASE WEEK CONFERENCE News waltham, mass., may 07, 2024 (globe newswire) -- ardelyx, inc. (nasdaq: ardx), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that additional data supporting ibsrela® (tenapanor) will be presented at the 2024 digestive disease week conference (ddw), to be held may 18-21, 2024, in washington, d.c. ibsrela is approved by the u.s. food and drug administration to treat irritable bowel syndrome with constipation (ibs-c) in adults. News 2 days ago | Buy |
75 | CPNG | Coupang, Inc. | $21.61 | -8.65% | 27.489 M | Coupang, Inc.16 days ago COUPANG TO ANNOUNCE FIRST QUARTER 2024 RESULTS ON MAY 7, 2024 News seattle--(business wire)--coupang to announce first quarter 2024 results on may 7, 2024. News 16 days ago | Buy |
76 | MAX | MediaAlpha, Inc. | $20.27 | -8.61% | 3.576 M | MediaAlpha, Inc.1 day ago MEDIAALPHA ANNOUNCES PRICING OF SECONDARY OFFERING BY WHITE MOUNTAINS INSURANCE GROUP AND INSIGNIA CAPITAL GROUP News los angeles, may 07, 2024 (globe newswire) -- mediaalpha, inc. (“mediaalpha”) (nyse: max) today announced the pricing of the previously announced underwritten secondary public offering of 6,600,000 shares of its class a common stock by certain selling stockholders affiliated with white mountains insurance group and insignia capital group (the “selling stockholders”) at an offering price of $19.00 per share (before discounts and commissions). the offering is expected to close on may 10, 2024 subject to customary closing conditions. News 1 day ago | Buy |
77 | TRUP | Trupanion, Inc. | $23.36 | -8.57% | 468.47 K | Trupanion, Inc.2 days ago TRUPANION LAUNCHES FIRST ANNUAL VETERINARY APPRECIATION DAY™ AWARDS News seattle--(business wire)--in recognition of veterinary appreciation day™ and all the veterinary community does to support our beloved pets, trupanion (nasdaq: trup), the leading provider of medical insurance for cats and dogs announced its first annual veterinary appreciation day awards. in 2015, trupanion established june 18 as veterinary appreciation day to recognize and celebrate the veterinary community for their profound impact on the lives of pets and their families. starting may 7, pet p. News 2 days ago | Buy |
78 | ADCT | ADC Therapeutics SA | $4.42 | -8.56% | 414.782 K | ADC Therapeutics SA3 days ago ADC THERAPEUTICS ANNOUNCES $105 MILLION UNDERWRITTEN OFFERING OF COMMON SHARES AND PRE-FUNDED WARRANTS News lausanne, switzerland, may 06, 2024 (globe newswire) -- adc therapeutics sa (nyse: adct) today announced that it has agreed to sell, by way of an underwritten offering, 13,411,912 of its common shares at a price of $4.900 per share and, to certain investors who so choose in lieu of common shares, pre-funded warrants to purchase 8,163,265 common shares at a price of $4.812 per pre-funded warrant (being the offering price per common share in the offering minus the exercise price). the gross proceeds from the offering, before deducting the underwriting discount and offering expenses payable by the company and assuming no exercise of the pre-funded warrants, are expected to be approximately $105.0 million. the offering is expected to close on may 8, 2024, subject to customary closing conditions. News 3 days ago | Buy |
79 | CTV | Innovid Corp. | $2.03 | -8.56% | 202.501 K | Innovid Corp.2 days ago INNOVID REPORTS Q1 2024 FINANCIAL RESULTS News new york--(business wire)--innovid corp. (nyse:ctv) (the "company"), an independent software platform for the creation, delivery, measurement, and optimization of advertising across connected tv (ctv), linear tv, and digital, today announced financial results for the first quarter ended march 31, 2024. “we're very proud to start 2024 with solid business momentum. we exceeded our revenue and adjusted ebitda guidance, demonstrated continuous improvement, and generated positive free cash flow for. News 2 days ago | Buy |
80 | GLP | Global Partners LP | $44.26 | -8.52% | 130.382 K | Global Partners LP22 hours ago GLOBAL PARTNERS LP REPORTS FIRST-QUARTER 2024 FINANCIAL RESULTS News waltham, mass.--(business wire)--global partners lp (nyse: glp) (“global” or the “partnership”) today reported financial results for the first quarter ended march 31, 2024. ceo commentary eric slifka, the partnership's president and chief executive officer, said, “our gasoline distribution and station operations segment performed well in the first quarter, posting healthy margins that partly offset less favorable market conditions in our wholesale and commercial segments. specific to our wholes. News 22 hours ago | Buy |
81 | CRSR | Corsair Gaming, Inc. | $10.76 | -8.5% | 705.001 K | Corsair Gaming, Inc.2 days ago CORSAIR GAMING REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News milpitas, calif.--(business wire)---- $crsr--corsair gaming, inc. (nasdaq: crsr) (“corsair” or the “company”), a leading global provider and innovator of high-performance products for gamers, streamers, content-creators, and gaming pc builders, today announced financial results for the first quarter ended march 31, 2024. first quarter 2024 select financial metrics net revenue was $337.3 million compared to $417.3 million in the fourth quarter of 2023 and $354.0 million in the first quarter of 2023. gamin. News 2 days ago | Buy |
82 | MAIA | MAIA Biotechnology, Inc. | $3.08 | -8.43% | 213.651 K | MAIA Biotechnology, Inc.9 days ago MAIA BIOTECHNOLOGY ANNOUNCES SHARE PURCHASE BY DIRECTOR ADELINA LOUIE IN PRIVATE PLACEMENT News chicago--(business wire)--maia biotechnology announces share purchase by director adelina louie in private placement. News 9 days ago | N/A |
83 | GLBE | Global-E Online Ltd. | $29.94 | -8.43% | 2.434 M | Global-E Online Ltd.3 days ago GLOBAL-E TO ANNOUNCE FINANCIAL RESULTS FOR THE FIRST QUARTER 2024 ON MAY 20, 2024 News petah-tikva, israel, may 06, 2024 (globe newswire) -- global-e online ltd. (nasdaq: glbe) the leader of global direct-to-consumer ecommerce enablement, today announced it will report financial results for the first quarter ended march 31, 2024, before market open on monday, may 20, 2024. News 3 days ago | Buy |
84 | GSUN | Golden Sun Health Technology Group Limited | $4.6 | -8.37% | 781.89 K | Golden Sun Health Technology Group Limited2 months ago GOLDEN SUN HEALTH TECHNOLOGY GROUP LIMITED ANNOUNCES RECEIPT OF NASDAQ DELISTING DETERMINATION AND PLAN TO APPEAL News shanghai, china, march 25, 2024 (globe newswire) -- golden sun health technology group limited, formerly known as golden sun education group limited (the “company” or “golden sun”) (nasdaq: gsun), a provider of tutorial services in china, today announced the company received a staff determination letter (the “letter”), on march 21, 2024, from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) notifying the company that, due to the company's failure to regain compliance with a minimum bid price of $1.00 per share requirement for continued listing on the nasdaq capital market, as set forth in nasdaq listing rule 5550(a)(2) (the "minimum bid requirement"), the staff has determined (the “determination”) that company's securities will be scheduled for delisting from nasdaq unless the company requests an appeal of this determination to a hearings panel (the "panel"). News 2 months ago | N/A |
85 | PHVS | Pharvaris N.V. | $20.73 | -8.36% | 19.53 K | Pharvaris N.V.29 days ago PHARVARIS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE News zug, switzerland, april 10, 2024 (globe newswire) -- pharvaris (nasdaq: phvs), a late-stage biopharmaceutical company developing novel, oral bradykinin b2 receptor antagonists to treat and prevent hereditary angioedema (hae) attacks, today reported financial results for the fourth quarter and year ended december 31, 2023 and provided a business update. News 29 days ago | Buy |
86 | IPSC | Century Therapeutics, Inc. | $3.09 | -8.31% | 58.327 K | Century Therapeutics, Inc.16 days ago CENTURY THERAPEUTICS TO PRESENT AT CHARDAN'S 8TH ANNUAL GENETIC MEDICINES AND CELL THERAPY MANUFACTURING SUMMIT News philadelphia, april 23, 2024 (globe newswire) -- century therapeutics (nasdaq: ipsc), an innovative biotechnology company developing induced pluripotent stem cell (ipsc)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that members of the management team will participate in a virtual fireside chat and panel at chardan's 8th annual genetic medicines and cell therapy manufacturing summit, details of the presentations are as follows: News 16 days ago | Buy |
87 | EVEX | Eve Holding, Inc. | $5.12 | -8.24% | 62.202 K | Eve Holding, Inc.2 months ago EMBRAER SELECTS DASSAULT SYSTÈMES' SIMULATION TECHNOLOGY TO SUPPORT QUIETER EVTOL AIRCRAFT DEVELOPMENT FOR EVE AIR MOBILITY News velizy-villacoublay, france--(business wire)-- #3dexperience--dassault systèmes (euronext paris: fr0014003tt8, dsy.pa) and embraer (nyse: erj; b3: embr3) announced today that dassault systèmes' simulation technology has been utilized to simulate, analyze and test virtually eve air mobility's (nyse: evex) electric vertical take-off and landing (evtol) aircraft. dassault systèmes' simulia powerflow application has provided robust and industry-proven fluid dynamics simulation to predict real-world operating condi. News 2 months ago | N/A |
88 | TWLO | Twilio Inc. | $58.16 | -8.22% | 6.891 M | Twilio Inc.3 days ago TWILIO APPOINTS CHRIS KOEHLER CHIEF MARKETING OFFICER News san francisco--(business wire)--twilio (nyse: twlo), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, today announced that chris koehler has been appointed chief marketing officer. chris brings over 25 years of expertise in customer engagement and marketing technology, and a proven track record of driving growth and innovation at industry-leading companies. as cmo, chris will report to chief executive officer khozema shipchandler, and. News 3 days ago | Buy |
89 | VPG | Vishay Precision Group, Inc. | $30.8 | -8.14% | 67.639 K | Vishay Precision Group, Inc.2 days ago VPG REPORTS FISCAL 2024 FIRST QUARTER RESULTS News malvern, pa., may 07, 2024 (globe newswire) -- vishay precision group, inc. (nyse: vpg), a leader in precision measurement and sensing technologies, today announced its results for its 2024 first fiscal quarter ended march 30, 2024. News 2 days ago | N/A |
90 | AQST | Aquestive Therapeutics, Inc. | $3.11 | -8.14% | 2.457 M | Aquestive Therapeutics, Inc.2 days ago AQUESTIVE THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE News warren, n.j., may 07, 2024 (globe newswire) -- aquestive therapeutics, inc. (nasdaq:aqst), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, reported financial results for the first quarter, which ended march 31, 2024, and provided an update on recent developments in its business. News 2 days ago | Buy |
91 | JOBY | Joby Aviation, Inc. | $4.94 | -8.08% | 6.93 M | Joby Aviation, Inc.2 days ago JOBY REPORTS FIRST QUARTER 2024 RESULTS News santa cruz, calif.--(business wire)--joby aviation, inc. (nyse:joby), a company developing electric air taxis for commercial passenger service, today issued its first quarter 2024 shareholder letter detailing the company's operational and financial results for the period ending march 31, 2024. the company will host a live audio webcast of its conference call to discuss the results at 2:00 p.m. pt (5:00 p.m. et) today. first quarter 2024 highlights: production ramp-up. our second production prot. News 2 days ago | Buy |
92 | ELYM | Eliem Therapeutics, Inc | $9.38 | -8.04% | 279.564 K | Eliem Therapeutics, Inc24 days ago SHAREHOLDER ALERT: KASKELA LAW LLC ANNOUNCES INVESTIGATION OF ELIEM THERAPEUTICS, INC. (ELYM) AND ENCOURAGES INVESTORS TO CONTACT THE FIRM News philadelphia , april 15, 2024 /prnewswire/ -- kaskela law llc, announces that it is investigating eliem therapeutics, inc. (nasdaq: elym) ("eliem") on behalf of the company's shareholders. the investigation seeks to determine whether eliem issued false and misleading statements and/or failed to disclose material facts to investors in connection with recent corporate actions, thereby violating the securities laws and causing harm to the company's shareholders. News 24 days ago | Buy |
93 | BPTH | Bio-Path Holdings, Inc. | $2.76 | -8% | 58.482 K | Bio-Path Holdings, Inc.23 hours ago BIO-PATH HOLDINGS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 15, 2024 News houston, may 08, 2024 (globe newswire) -- bio-path holdings, inc., (nasdaq: bpth) a biotechnology company leveraging its proprietary dnabilize® antisense rnai nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on wednesday, may 15, 2024 at 8:30 a.m. et to report financial results for the first quarter ended march 31, 2024 and to provide a business overview. News 23 hours ago | Buy |
94 | KLXE | KLX Energy Services Holdings, Inc. | $6.1 | -7.99% | 525.127 K | KLX Energy Services Holdings, Inc.2 days ago KLX ENERGY SERVICES HOLDINGS, INC. REPORTS FIRST QUARTER 2024 RESULTS News houston , may 7, 2024 /prnewswire/ -- klx energy services holdings, inc. (nasdaq: klxe) ("klx", the "company", "we", "us" or "our") today reported financial results for the first quarter ended march 31, 2024. first quarter 2024 financial highlights revenue of $175 million net loss of $(22) million and diluted loss per share of $(1.38) adjusted ebitda of $12 million net loss margin of (13)% adjusted ebitda margin of 7% liquidity of $128 million, consisting of approximately $85 million of cash and approximately $43 million of available borrowing capacity under the march 2024 asset-based revolving credit facility (the "abl facility") borrowing base certificate set what we believe to be a new us coiled tubing depth record of 28,915 feet see "non-gaap financial measures" at the end of this release for a discussion of adjusted ebitda, adjusted ebitda margin, adjusted net (loss) income, adjusted diluted (loss) earnings per share, unlevered and levered free cash flow, net working capital, net debt, net leverage ratio and their reconciliations to the most directly comparable financial measure calculated and presented in accordance with u.s. generally accepted accounting principles ("gaap"). News 2 days ago | Hold |
95 | ANRO | Alto Neuroscience, Inc. | $13.82 | -7.93% | 38.698 K | Alto Neuroscience, Inc.16 days ago ALTO NEUROSCIENCE ANNOUNCES POSITIVE PHASE 1 RESULTS FOR ALTO-101, A NOVEL PDE4 INHIBITOR IN DEVELOPMENT FOR SCHIZOPHRENIA News los altos, calif.--(business wire)--alto neuroscience, inc. (“alto”) (nyse: anro) today announced positive results from its healthy volunteer phase 1 study of alto-101, a novel pde4 inhibitor in development for cognitive impairment associated with schizophrenia (cias). results from the study demonstrated favorable tolerability and improved pharmacokinetics of alto-101 when administered via a transdermal delivery system (tds) compared to oral administration. the tds formulation is being develope. News 16 days ago | N/A |
96 | GETY | Getty Images Holdings, Inc. | $3.78 | -7.93% | 306.403 K | Getty Images Holdings, Inc.9 days ago NEARLY 90% OF CONSUMERS WANT TRANSPARENCY ON AI IMAGES FINDS GETTY IMAGES REPORT News getty images visualgps report outlines crucial guidance for brands grappling with the question: should i be using generative ai, and if yes, how and when? News 9 days ago | Buy |
97 | SNCY | Sun Country Airlines Holdings, Inc. | $11.35 | -7.87% | 636.189 K | Sun Country Airlines Holdings, Inc.2 days ago SUN COUNTRY AIRLINES REPORTS FIRST QUARTER 2024 RESULTS News revenue of $311 million, highest first quarter on record(1) gaap diluted eps of $0.64 and operating income of $55 millionadj. diluted eps(2) of $0.66 and adjusted operating income(2) of $57 million, minneapolis, may 07, 2024 (globe newswire) -- sun country airlines holdings, inc. (“sun country airlines,” “sun country,” the “company”) (nasdaq: sncy) today reported financial results for its first quarter ended march 31, 2024. News 2 days ago | Buy |
98 | RRR | Red Rock Resorts, Inc. | $50.1 | -7.85% | 1.716 M | Red Rock Resorts, Inc.2 days ago RED ROCK RESORTS ANNOUNCES FIRST QUARTER 2024 RESULTS News las vegas , may 7, 2024 /prnewswire/ -- red rock resorts, inc. ("red rock resorts," "we" or the "company") (nasdaq: rrr) today reported financial results for the first quarter ended march 31, 2024. first quarter results consolidated operations net revenues were $488.9 million for the first quarter of 2024, an increase of 12.7%, or $55.3 million, from $433.6 million in the same period of 2023. News 2 days ago | Buy |
99 | TSVT | 2seventy bio, Inc. | $4.58 | -7.76% | 542.446 K | 2seventy bio, Inc.6 days ago 2SEVENTY BIO TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 8, 2024 News cambridge, mass.--(business wire)--2seventy bio, inc. (nasdaq: tsvt) will announce its first quarter 2024 financial results on wednesday, may 8, 2024. a conference call and webcast will be held at 8:00 a.m. et. participants can access the conference call live via webcast which will be available on the investors and media page of the company's website at https://ir.2seventybio.com. participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the c. News 6 days ago | Buy |